Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

PellePharm Investigative Site, Brussels

PellePharm Investigative Site, Leuven

Maastricht University Medical Center - Dept of Dermatology, Maastricht

Columbia University Medical Center, New York

Charite - Universitatsmedizin Berlin, Berlin

CHU La Timone, Marseille

Penn State Health Milton S. Hershey Medical Center, Hershey

Hospital of the University of Pennsylvania, Philadelphia

Humanitas University Milan, Rozzano

Duke University, Durham

Hospital Universitario Ramon y Cajal, Madrid

Leavitt Medical Associates of Florida, Ormond Beach

Hopital Saint-Andre - CHU Bordeaux, Bordeaux

University of Miami Miller School of Medicine, Miami

Ospedale San Bortolo, Vicenza

Hospital Universitiario Virgen de la Macarena, Seville

PellePharm Investigative Site, Nantes

Cleveland Clinic Foundation, Cleveland

Laser & Skin Surgery Center of Indiana, Carmel

Universitatsklinikum Münster, Münster

University of Minnesota, Department of Dermatology, Minneapolis

CHRU de Lille - Hopital Claude HURIEZ, Lille

The University of Chicago, Chicago

Saint Louis University Dermatology, St Louis

PellePharm Investigative Site, Pierre-Bénite

Universitats Hautklinik, Tübingen

Hopital Saint-Louis, Paris

MD Anderson Cancer Center, Houston

Ospedale Vanvitelli-University della Campania-Dermatologia Edificio 9, Napoli

Klinik und Poliklinik fur Dermatologie und Allergologie, Munich

University of Utah Midvalley Dermatology, Murray

Mayo Clinical Cancer Center, Phoenix

Dermatology Center of Newport, Newport Beach

Stanford University, Department of Dermatology, Redwood City

University of California, San Francisco, San Francisco

Oregon Health and Science University, Portland

Yale School of Medicine, New Haven

Dana-Farber Cancer Institute, Boston

University of Michigan, Dept of Dermatology, Ann Arbor

Dartmouth-Hitchcock Medical Center, Lebanon

Clinical Trials Unit - The Skin Care Centre, Vancouver

PellePharm Investigative Site, Copenhagen

Pellepharm Investigative Site, Toronto

Catholic University of the Sacred Heart, Roma

Hospital Clinic I Provincial, Barcelona

NHS Greater Glasgow and Clyde, Glasgow

Royal London Hospital, London

Oxford University Hospitals NHS Foundation Trust, Oxford

Salford Royal Hospital, Salford